• 제목/요약/키워드: Patient with Terminal Cancer

검색결과 124건 처리시간 0.03초

말기 암환자의 총체적 고통 (Total Pain of Patient with Terminal Cancer)

  • 이원희
    • Journal of Hospice and Palliative Care
    • /
    • 제3권1호
    • /
    • pp.60-73
    • /
    • 2000
  • 목적 : 연구의 목적은 말기 암환자의 총체적 고통의 내용과 총체적 고통의 관련요인을 파악하는 것이다. 방법 : 본 연구는 후향적 서술적 연구로 연구의 표본은 1단계에서는 1997년에 일개 대학에서 운영하는 호스피스 사업소에 등록된 환자전수를 대상으로 하였고 2단계에서는 4명의 호스피스 간호사에 의해 선정된 가장 고통이 심한 5명의 환자를 대상으로 하였다. 자료 수집 방법은 Twycross model의 분류 틀을 사용하여 호스피스 환자의 의무기록지를 분석하고 5명의 환자들을 담당하였던 호스피스 간호사와의 심층면담을 통해 의무기록지의 내용을 보충하였다. 또한 호스피스 정규 Team meeting시 사례연구를 통하여 고통의 내용과 관련요인을 확인하였다. 자료의 분석은 SPSS를 이용하여 서술적 통계를 사용하였고 간호사와의 심층 면담은 내용을 분석하였다. 결과 : 말기 암환자들이 주로 경험하는 주요문제들은 통증과 변비, 가족대응, 영적 고뇌(우울, 불안 등) 등으로 통증조절뿐만 아니라 가족의 대응 및 지지, 심리적 영적 지지와 함께 다른 증상조절에 필요한 적절한 간호중재가 요구됨을 나타내고 있다. Twycross model이 문화적인 차이가 있는 한국에도 정도의 차이는 있지만 죽음이라는 사실을 당면한 환자에게 유용한 총체적 고통 model로 사료된다. 결론 : 본 연구의 결과 Twycross model이 한국적 상황에서의 총체적 고통을 설명하는데 유용하였으나 새로운 요인들이 첨가되었으므로 한국의 말기 암환자에 대한 평가가 필요하다.

  • PDF

말기 암환자의 통증 및 통증관리에 영향을 미치는 요인 (Pain and Factors Influencing Its Management in Patients with Terminal Cancer)

  • 윤영호;허대석;김홍수;오상우;유태우;김유영;허봉렬
    • Journal of Hospice and Palliative Care
    • /
    • 제1권1호
    • /
    • pp.23-29
    • /
    • 1998
  • 목적: WHO의 통증관리원칙에 따른 통증관리의 효과가 입증되었으며 불충분한 통증관리의 문제점을 해결하려는 많은 노력이 있어 왔다. 본 연구는 말기암환자들의 통증정도와 불충분한 통증관리에 영향을 미치는 환자의 특성을 밝히고자 하였다. 방법: 1997년 6월부터 1997년 11월까지 서울대학교병원에서 말기암으로 판정받은 성인 암환자 100명을 대상으로 활동도, 전이여부 등을 포함한 인구 의학적 특성과, 사용되고 있는 진통제를 보정한 통증정도를 조사하였다. WHO의 통증관리지침에 따라 통증관리의 적절성을 평가하였으며 이에 영향을 미치는 환자의 특성을 조사하였다. 결과: 말기암판정당시 85%의 환자들이 통증이 있었으며 65%의 환자들이 중등도이상의 통증을 갖고 있었다. 말기암환자 38%가 불충분한 통증관리를 받고 있었으며 통증의 정도가 심할수록 불충분한 통증관리를 받고 있었다(P<0.001). 성별 연령, 암의 원발부위, 전이여부, 우울 및 불안 증상, 활동도는 통계적 유의성이 없었다. 결론: 통증관리지침이 제시되었음에도 불구하고 많은 말기암환자들이 충분한 통증관리를 받지 못하고 있다. 이를 해결하기 위해서 통증 평가방법과 통증관리지침에 관한 적극적인 교육 및 훈련이 필요하다.

  • PDF

말기 유방암 환자에서 발생한 흉막 전이에 의한 거대 종양 1예와 호흡곤란의 치료 (A Case of a Huge Mass Due to Pleural Metastasis and Management of Dyspnea in a Patient with Terminal Breast Cancer)

  • 이나리
    • Journal of Hospice and Palliative Care
    • /
    • 제17권2호
    • /
    • pp.85-89
    • /
    • 2014
  • 유방암 환자의 흉막 전이는 흔한 소견이다. 흉수가 가장 흔한 증상이고 흉수를 동반하지 않는 흉막 결절이나 흉막 판은 비교적 드물다. 본 환자는 말기 유방암으로 인해 흉수를 동반하지 않는 빠른 속도로 악화되는 거대 흉막 종양이 생겨났고 그로 인해 심한 호흡곤란을 경험했던 환자로 보기 드문 증례로서 보고를 하며 이와함께 말기암환자의 호흡곤란의 치료에 대해 고찰해 보고자 한다.

지주막하강내 약물투여에 의한 말기암 환자의 통증관리 -증례 보고- (Pain Management of Terminal Cancer Patients by Intrathecal Injection of Local Anesthetics, Opioid and Adjuvants -A report of two cases-)

  • 이선화;김종일;이상곤;반종석;민병우
    • The Korean Journal of Pain
    • /
    • 제13권2호
    • /
    • pp.259-262
    • /
    • 2000
  • There are many difficulties in the management of terminal cancer pain. We often encounter difficulties when nerve blocks or epidural injection of drugs do not produce good results. Local anesthetics, opioids and adjunctives, were administered to two patients intrathecally. The results were very satisfactory. It has complications such as hypotension or infection due to intrathecal route. In the first case, the pancreatic cancer patient complicated with severe epigastic pain but unfortunately no management was effective in pain control. Intrathecal injection of bupivacaine and morphine mixture was successful even if syncope which was relieved by bed rest. In the second case, the patient complicated with lower abdominal pain due to ovarian cancer who very well controlled by epidural injection of morphine and clonidine mixture but morphine demand was greatly increased. Intrathecal injection of morphine and ketamine were tried. The patient had comportable analgesic effect. CSF leakage to subcutaneous occurred but resolved by change of the catheter position or retunnelling. There were no significant complications reported in two cases.

  • PDF

암성통증환자의 통증완화법과 실태에 대한 연구 (The Clinical Evaluation in Cancer Pain Management)

  • 백승완;변병호;채명길
    • The Korean Journal of Pain
    • /
    • 제11권2호
    • /
    • pp.214-219
    • /
    • 1998
  • Pain is one of the most frequent and disturbing symptom of cancer patients. And almost of cancer patients are afraid of a attacks of pain related to cancer. Caring for the cancer patient can be divided into two phases. The phase of "active treatment" involves various interventions-surgical, chemical or radiological- that are designed to prolong the patient's life. "Terminal care" is the period from the end of active treatment until the patient's death. But in the majority of clinical settings, cancer pain is not being managed adequately results from a lack of education about how to treat the cancer pain management in the safest and most effective way during terminal phase. Althought organic factors represent the most important cause of their pain, it is also important to deal with the patient's psychological reactions and to take account of his or her social and family environment if treatment for chronic cancer pain is to prove adequate. Thus we try to evaluate a kinds of cancer related to pain, degree of pain, effectiveness of drugs, and patient's responses to management. In regard to the satisfaction for pain relief in pain clinics at Pusan National University Hospital(PNUH) are about 70% in patients and 90% in family. Average life expectancy in cancer patients are about 140 days (3 days- 5.7 years). Cancer patients are complained of several discomfortness (above 30 kinds) such as, pain associated with cancer (75%), nausea and vomitting (38%), sleeping disorder (38%), anorexia (38%), dyspnea (32%), constipation (31%), etc. Distributions of cancer associated with pain are stomach cancer (21%), lung cancer (16%), cervix cancer (10%), anorectal and colon cancer (8.6%), hepatoma (8%), pancreatic cancer (3%). About 1/3 of patients are suffer from incident pain in 3~5 times in a day especially in moving, coughing, and exercise. Methods for drug delivering system before death are transdermal fentanyl patch (42%), intravenous PCA (21%), oral intake of opioid (17%), epidural PCA (14%), etc.

  • PDF

Clinical Observation of Multiple Metastatic Cancer Patient with Hepatocellular Carcinoma treated with Cultivated Wild Ginseng Herbal Acupuncture Therapy

  • Kwon, Ki-Rok;Park, Chi-Wan;Ra, Min-Soo;Cho, Chong-Kwan
    • Journal of Acupuncture Research
    • /
    • 제22권2호
    • /
    • pp.211-217
    • /
    • 2005
  • Objectives : Terminal stage cancer patient from primary hepatocellular carcinoma metastasized into lungs was administered with cultivated wild ginseng herbal acupuncture for 5 months and observed progression. Methods : Cultivated wild ginseng herbal acupuncture was administered 5 times a week at about 150cc dosage per week. Dynamic CT was taken and interpreted at a university hospital. Results : Above patient was diagnosed with hepatocellular carcinoma and received one procedure of lobectomy and three procedures of TACE, but because of metastasis, chance of improvement was very obscure. Intensive treatment of cultivated wild ginseng herbal acupuncture five times a week for five months in association with moxibustion was done on the patient. Near elimination of the cancer cells metastasized into lungs were confirmed in terms of radiological impression through dynamic CT. Conclusion: From the results obtained in this study, cultivated wild ginseng herbal acupuncture can be an effective measure against terminal stage cancer. But this is a single case study and lack of extensive follow-up must be compensated by further researches.

  • PDF

호스피스 간호시 말기 암환자의 임종 현상 연구 -독립형 호스피스 센타를 중심으로- (A Study of the Experience of Patients with Terminal Cancer Who are in an Independent Hospice Center)

  • 김분한;탁영란;전미영
    • 대한간호학회지
    • /
    • 제26권3호
    • /
    • pp.668-677
    • /
    • 1996
  • This study is a phenomenological study done to promote understanding of the dying process in patients with terminal cancer who were in an independent hospice center. The purpose of study was to explore and understand indepth information on the dying process in order to provide data for holistic hospice care in nursing and to give insights in to practical applications in the nursing care In-depth interviewing was done from may, through November, 1995 with 11 patient with cancer who were being cared for at K Hospice Care Center. Experiences in the dying process were discussed as they expressed feelings about death including (a) feeling of isolation because family members try to hide the diagnosis of cancer. (b) hopelessness, (c) guilt, anger, and hostility, (d) suffering from pain, (e) fear of death. However, subjects did not deny death itself and were developing peace of mind and acceptance of death through religion.

  • PDF

말기 대장암환자에서 중상을 통한 예후 측정 및 증상조절 (Predicting Life Span for Terminal Colon Cancer using Clinical Symptoms)

  • 이도행;최윤선;홍명호;김준석;이경진;김영수
    • Journal of Hospice and Palliative Care
    • /
    • 제2권2호
    • /
    • pp.138-143
    • /
    • 1999
  • Accurately estimating survival times in terminal cancer patients is very difficult for palliative care clinicians. But a reasonably accurate estimate of survival would permit the medical team to : Plan the ideal therapeutic strategy between overtreatment and too early discontinuation of specific therapy. Answer any questions asked by the patient or family. Organize adequate assistance for the patient concerned. Decide on the eligibility of the patient for clinical trials and whether to begin a treatment, the effects of which will not be immediate. This case was a 79 year-old male patient with colon cancer. He complained of dry mouth, anorexia, weight loss and showed KPS $40{\sim}50$ on admission day. 40 days later he died. To improve patient/family quality of life, it is necessary to improve the ability to estimate accurately a patient's length of survival.

  • PDF

Factors Associated with Place of Death in Korean Patients with Terminal Cancer

  • Hyun, Min Kyung;Jung, Kyung Hae;Yun, Young Ho;Kim, Young Ae;Lee, Woo Jin;Do, Young Rok;Lee, Keun Seok;Heo, Dae Seog;Choi, Jong Soo;Kim, Sam Yong;Kim, Heung Tae;Hong, Seok-Won
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권12호
    • /
    • pp.7309-7314
    • /
    • 2013
  • Aim: To investigate factors that affect the place of death (POD) of terminal cancer patients. Materials and Methods: We recruited 702 consecutive patients (${\geq}18$ years) from 12 centers during July 2005 to October 2006, and 481 completed the questionnaire. In April 2011, we linked the data for 96.0% (n=462) of the deceased patients to the POD using the 2005-2009 death certificate data of Korea's National Statistical Office. The primary outcome variable was POD, and the predictive value of variables pertaining to patients and caregivers was evaluated using univariate and multivariate analyses. Results: Most patients died in a hospital (91.5%, n=441) and age, education, preference for place of terminal care, wish to use hospice/palliative care services, terminal cancer awareness, time between diagnosis and death, and global quality-of-life subscale of the EORTC QLQ-C30 of patients, and education and preference for place of terminal care of caregivers were significant predictors in univariate analyses. On multivariate analysis, patients and caregivers who preferred hospital/palliative care as the terminal care option over home care [adjusted odds ratio (aOR), 2.68; 95% confidential interval (CI), 1.18-7.04 and aOR: 2.65; 95%CI: 1.15-6.09 for patient and caregiver preferences, respectively] and caregivers who were highly educated (aOR, 3.19; 95%CI, 1.44-7.06) were predictors of POD. Conclusions: Most of the terminal cancer patients died in a hospital. Our findings indicate that major predictors of hospital deaths are preference of both the patient and caregiver for hospital/palliative care as the terminal care option and higher education of the caregiver.

A Clinical Observation of Oriental Medicine-Based Long Care for Terminal Rectal Cancer Patient with Multiple Metastasis

  • 방선휘;손창규
    • 대한한방내과학회지
    • /
    • 제29권3호
    • /
    • pp.567-573
    • /
    • 2008
  • 암은 현대의 모든 선진국에서 가장 주요한 사망의 원인이다. 통상적인 암 치료의 낮은 효율과 삶의 질의 중요성의 측면에서, 보완대체의학은 말기의 암 환자들에게 전 세계적으로 널리 수용되어지고 있다. 한의학은 전통적으로 종양 자체뿐만 아니라 암을 지닌 몸 전체를 함께 강조해 왔으며, 그로 인하여 종양면역을 개선시키고 환자의 삶의 질을 개선시키며 생존기간을 연장하는데 일조한다고 여겨진다. 저자는 여기에서 전신에 전이가 이루어진 말기의 직장암 환자가 한방치료를 4년 정도 받으면서 양호한 임상경과를 보여 온 환자를 보고하는 바이다. 본 연구가 암성 질환에 있어 한의학의 임상적 효용성의 예를 통하여 한의학 기반의 암 치료법의 개발과 발전에 일조하길 희망한다.

  • PDF